Strategic Acquisition Growth Spectranetics has demonstrated significant expansion through acquisitions, notably purchasing AngioScore for 230 million dollars in 2014, which bolstered its product portfolio and market presence in cardiovascular devices. This suggests ongoing growth opportunities for complementary product lines and integration services.

Strong Industry Presence As a mid-sized medical device manufacturer with up to 1000 employees, Spectranetics operates within the competitive medical equipment manufacturing industry, primarily focusing on innovative solutions for cardiovascular procedures, presenting opportunities to support or upgrade existing product technologies.

Merged with Philips Being part of Philips, a global leader in health technology, provides access to an extensive distribution network and advanced R&D capabilities. Sales efforts can leverage this relationship to introduce new products or services aligned with Philips' strategic focus on cardiovascular and health innovations.

Product Innovation & Clinical Trials Recent product launches, such as the Bridge occlusion balloon with 100% survival data in clinical trials, position Spectranetics as a leader in innovative medical solutions. These advancements create opportunities to promote related accessories, consumables, and support services for hospitals and clinics.

Revenue & Market Potential With an estimated revenue of 50 to 100 million dollars, Spectranetics holds a significant market share in cardiovascular device solutions. Targeted sales efforts can focus on expanding into new hospitals and healthcare systems seeking cutting-edge minimally invasive procedures.